81 related articles for article (PubMed ID: 1379973)
1. p185 HER2/neu epitope mapping with murine monoclonal antibodies.
Centis F; Tagliabue E; Uppugunduri S; Pellegrini R; Martignone S; Mastroianni A; Ménard S; Colnaghi MI
Hybridoma; 1992 Jun; 11(3):267-76. PubMed ID: 1379973
[TBL] [Abstract][Full Text] [Related]
2. Antigenic and immunogenic mimicry of the HER2/neu oncoprotein by phage-displayed peptides.
Orlandi R; Ménard S; Colnaghi MI; Boyer CM; Felici F
Eur J Immunol; 1994 Nov; 24(11):2868-73. PubMed ID: 7525309
[TBL] [Abstract][Full Text] [Related]
3. Selection of monoclonal antibodies which induce internalization and phosphorylation of p185HER2 and growth inhibition of cells with HER2/NEU gene amplification.
Tagliabue E; Centis F; Campiglio M; Mastroianni A; Martignone S; Pellegrini R; Casalini P; Lanzi C; Ménard S; Colnaghi MI
Int J Cancer; 1991 Apr; 47(6):933-7. PubMed ID: 1672668
[TBL] [Abstract][Full Text] [Related]
4. Production and characterization of murine mAbs to the extracellular domain of human neu oncogene product GP185HER2.
Digiesi G; Giacomini P; Fraioli R; Mariani M; Nicotra MR; Segatto O; Natali PG
Hybridoma; 1992 Aug; 11(4):519-27. PubMed ID: 1383128
[TBL] [Abstract][Full Text] [Related]
5. Both the epitope specificity and isotype are important in the antitumor effect of monoclonal antibodies against Her-2/neu antigen.
Kim KM; Shin EY; Moon JH; Heo TH; Lee JY; Chung Y; Lee YJ; Cho HM; Shin SU; Kang CY
Int J Cancer; 2002 Dec; 102(4):428-34. PubMed ID: 12402315
[TBL] [Abstract][Full Text] [Related]
6. Antibody-induced growth inhibition is mediated through immunochemically and functionally distinct epitopes on the extracellular domain of the c-erbB-2 (HER-2/neu) gene product p185.
Xu F; Lupu R; Rodriguez GC; Whitaker RS; Boente MP; Berchuck A; Yu Y; DeSombre KA; Boyer CM; Bast RC
Int J Cancer; 1993 Feb; 53(3):401-8. PubMed ID: 7679090
[TBL] [Abstract][Full Text] [Related]
7. The extracellular domain of the c-erbB-2 oncoprotein is released from tumor cells by proteolytic cleavage.
Pupa SM; Ménard S; Morelli D; Pozzi B; De Palo G; Colnaghi MI
Oncogene; 1993 Nov; 8(11):2917-23. PubMed ID: 8105438
[TBL] [Abstract][Full Text] [Related]
8. Antibody-induced activation of p185HER2 in the human lung adenocarcinoma cell line Calu-3 requires bivalency.
Srinivas U; Tagliabue E; Campiglio M; Ménard S; Colnaghi MI
Cancer Immunol Immunother; 1993 Jun; 36(6):397-402. PubMed ID: 8098992
[TBL] [Abstract][Full Text] [Related]
9. Shared antigenic epitopes and pathobiological functions of anti-p185(her2/neu) monoclonal antibodies.
Zhang H; Wang Q; Montone KT; Peavey JE; Drebin JA; Greene MI; Murali R
Exp Mol Pathol; 1999 Sep; 67(1):15-25. PubMed ID: 10493889
[TBL] [Abstract][Full Text] [Related]
10. Expression of the p185 encoded by HER2 oncogene in normal and transformed human tissues.
Natali PG; Nicotra MR; Bigotti A; Venturo I; Slamon DJ; Fendly BM; Ullrich A
Int J Cancer; 1990 Mar; 45(3):457-61. PubMed ID: 1968437
[TBL] [Abstract][Full Text] [Related]
11. Targeting multiple Her-2 epitopes with monoclonal antibodies results in improved antigrowth activity of a human breast cancer cell line in vitro and in vivo.
Spiridon CI; Ghetie MA; Uhr J; Marches R; Li JL; Shen GL; Vitetta ES
Clin Cancer Res; 2002 Jun; 8(6):1720-30. PubMed ID: 12060609
[TBL] [Abstract][Full Text] [Related]
12. Characterization of murine monoclonal antibodies reactive to either the human epidermal growth factor receptor or HER2/neu gene product.
Fendly BM; Winget M; Hudziak RM; Lipari MT; Napier MA; Ullrich A
Cancer Res; 1990 Mar; 50(5):1550-8. PubMed ID: 1689212
[TBL] [Abstract][Full Text] [Related]
13. A linear region of a monoclonal antibody conformational epitope mapped on p185HER2 oncoprotein.
Orlandi R; Formantici C; Ménard S; Boyer CM; Wiener JR; Colnaghi M
Biol Chem; 1997 Nov; 378(11):1387-92. PubMed ID: 9426199
[TBL] [Abstract][Full Text] [Related]
14. Relative cytotoxic activity of immunotoxins reactive with different epitopes on the extracellular domain of the c-erbB-2 (HER-2/neu) gene product p185.
Boyer CM; Pusztai L; Wiener JR; Xu FJ; Dean GS; Bast BS; O'Briant KC; Greenwald M; DeSombre KA; Bast RC
Int J Cancer; 1999 Aug; 82(4):525-31. PubMed ID: 10404066
[TBL] [Abstract][Full Text] [Related]
15. Generation and characterization of monoclonal antibodies specific for the human neu oncogene product, p185.
McKenzie SJ; Marks PJ; Lam T; Morgan J; Panicali DL; Trimpe KL; Carney WP
Oncogene; 1989 May; 4(5):543-8. PubMed ID: 2566965
[TBL] [Abstract][Full Text] [Related]
16. Rat MAbs to the product of the c-erbB-2 proto-oncogene for diagnosis and therapy in breast cancer.
Dean CJ; Eccles SA; Valeri M; Box G; Allan S; McFarlane C; Sandle J; Styles J
Cell Biophys; 1993; 22(1-3):111-27. PubMed ID: 7534210
[TBL] [Abstract][Full Text] [Related]
17. Epitope-mapped monoclonal antibodies as tools for functional and morphological analyses of the human urokinase receptor in tumor tissue.
Luther T; Magdolen V; Albrecht S; Kasper M; Riemer C; Kessler H; Graeff H; Müller M; Schmitt M
Am J Pathol; 1997 Apr; 150(4):1231-44. PubMed ID: 9094980
[TBL] [Abstract][Full Text] [Related]
18. Differential binding patterns of monoclonal antibody 2C4 to the ErbB3-p185her2/neu and the EGFR-p185her2/neu complexes.
Cai Z; Zhang G; Zhou Z; Bembas K; Drebin JA; Greene MI; Zhang H
Oncogene; 2008 Jun; 27(27):3870-4. PubMed ID: 18264138
[TBL] [Abstract][Full Text] [Related]
19. Characterization of an anti-p185HER2 monoclonal antibody that stimulates receptor function and inhibits tumor cell growth.
Sarup JC; Johnson RM; King KL; Fendly BM; Lipari MT; Napier MA; Ullrich A; Shepard HM
Growth Regul; 1991 Jun; 1(2):72-82. PubMed ID: 1688187
[TBL] [Abstract][Full Text] [Related]
20. Gene-specific inhibition of breast carcinoma in BALB-neuT mice by active immunization with rat Neu or human ErbB receptors.
Masuelli L; Focaccetti C; Cereda V; Lista F; Vitolo D; Trono P; Gallo P; Amici A; Monaci P; Mattei M; Modesti M; Forni G; Kraus MH; Muraro R; Modesti A; Bei R
Int J Oncol; 2007 Feb; 30(2):381-92. PubMed ID: 17203220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
